{"pages_annotated": [], "figures": [{"page_width": 612, "caption_text": ["Figure 3 Physician satisfaction with current treatment at end of study.", "Note: Patients who changed treatment cohort during the observational period were not included in the analysis.", "Abbreviation: LABA, long-acting \u03b22-agonist."], "figure_type": "Figure", "region_bb": [148, 52, 342.0, 193.0], "caption_bb": [70.0, 255.0, 298.0, 29.0], "page": 7, "page_height": 792}, {"page_width": 612, "caption_text": ["Figure 4 Patient assessment of ease of use of indacaterol inhaler at end of study.", "Notes: aPatients who changed treatment during the observational period; inhaler ease of use was assessed until the time of treatment change in these patients."], "figure_type": "Figure", "region_bb": [132, 510.0, 316.0, 186.0], "caption_bb": [70.0, 705.0, 427.0, 19.0], "page": 7, "page_height": 792}, {"page_width": 612, "caption_text": ["Figure 4 Patient assessment of ease of use of indacaterol inhaler at end of study.", "Notes: aPatients who changed treatment during the observational period; inhaler ease of use was assessed until the time of treatment change in these patients."], "figure_type": "Figure", "region_bb": [70.0, 52, 470.0, 644.0], "caption_bb": [70.0, 705.0, 427.0, 19.0], "page": 7, "page_height": 792}, {"page_width": 612, "caption_text": ["Figure S2 Change from baseline in CCQ (A) symptoms score, (B) functional state score and (C) mental state score.", "Notes: Data are mean \u00b1 standard error. Last observation was carried forward. All P,0.0001 for change in CCQ from baseline to end of study. Per-protocol population.", "Abbreviations: CCQ, clinical COPD questionnaire; LABA, long-acting \u03b22-agonist."], "figure_type": "Figure", "region_bb": [52, 83, 489, 652], "caption_bb": [53.0, 476.0, 442.0, 29.0], "page": 12, "page_height": 792}, {"page_width": 612, "caption_text": ["Figure S2 (Continued)"], "figure_type": "Figure", "region_bb": [141, 520.0, 347, 171.0], "caption_bb": [70.0, 700.0, 70, 7], "page": 11, "page_height": 792}, {"page_width": 612, "caption_text": ["Figure 1 Changes from baseline in CCQ overall score.", "Notes: Data are mean \u00b1 standard error. Last observation was carried forward. All P,0.0001 for change in CCQ overall score from baseline to end of study.", "Abbreviations: CCQ, clinical COPD questionnaire; LABA, long-acting \u03b22-agonist."], "figure_type": "Figure", "region_bb": [113, 85, 369, 151.0], "caption_bb": [53.0, 245.0, 413.0, 29.0], "page": 6, "page_height": 792}, {"page_width": 612, "caption_text": ["Figure 2 Patient satisfaction with current treatment at end of study.", "Notes: aPatients who changed treatment during the observational period; treatment satisfaction was assessed until the time of treatment change in these patients.", "Abbreviation: LABA, long-acting \u03b22-agonist."], "figure_type": "Figure", "region_bb": [114, 481.0, 334.0, 206.0], "caption_bb": [53.0, 696.0, 433.0, 29.0], "page": 6, "page_height": 792}, {"page_width": 612, "caption_text": ["Figure 2 Patient satisfaction with current treatment at end of study.", "Notes: aPatients who changed treatment during the observational period; treatment satisfaction was assessed until the time of treatment change in these patients.", "Abbreviation: LABA, long-acting \u03b22-agonist."], "figure_type": "Figure", "region_bb": [53.0, 85, 474.0, 602.0], "caption_bb": [53.0, 696.0, 433.0, 29.0], "page": 6, "page_height": 792}, {"page_width": 612, "caption_text": ["Figure 5 Physician assessment of indacaterol inhaler ease of use at end of study.", "Note: Patients who changed treatment cohort during the observational period were not included in the analysis."], "figure_type": "Figure", "region_bb": [125, 54.0, 386.0, 183.0], "caption_bb": [53.0, 246.0, 298.0, 16.0], "page": 8, "page_height": 792}], "fig_no": 5}